Sign Out
VELCADE (bortezomib) for Injection is an antineoplastic agent available for intravenous injection (IV) or subcutaneous (SC) use. Each single use vial contains: 1.0 mg (IV use only) or 3.5 mg (IV or SC use) as a sterile lyophilized powder.
Each vial is contained in a transparent blister pack consisting of a tray with a lid. The 5 ml vial contains 11 mg powder for solution for injection and the 10 ml vial contains 38.5 mg powder for solution for injection.
Excipients/Inactive Ingredients: Mannitol (E421)
